Try our beta test site

Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)

This study has been completed.
Kuopio University Hospital
Information provided by (Responsible Party):
Laurantis Pharma, Ltd. Identifier:
First received: November 10, 2011
Last updated: May 15, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)